Jeffrey E. Russel

Array ( [id] => 3787156 [patent_doc_number] => 05840690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Regulation of cell proliferation and differentation using peptides' [patent_app_type] => 1 [patent_app_number] => 8/471576 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6606 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840690.pdf [firstpage_image] =>[orig_patent_app_number] => 471576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940945 [patent_doc_number] => 05872212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Pesticidal proteins and strains' [patent_app_type] => 1 [patent_app_number] => 8/470566 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21836 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872212.pdf [firstpage_image] =>[orig_patent_app_number] => 470566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761645 [patent_doc_number] => 05851989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Method of extending the plasma half-life of vascular endothelial cell growth factor' [patent_app_type] => 1 [patent_app_number] => 8/465895 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 10849 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851989.pdf [firstpage_image] =>[orig_patent_app_number] => 465895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3816330 [patent_doc_number] => 05770562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Products and methods for improving keratinocyte adhesion to the dermis' [patent_app_type] => 1 [patent_app_number] => 8/469500 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 54 [patent_no_of_words] => 17304 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770562.pdf [firstpage_image] =>[orig_patent_app_number] => 469500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807620 [patent_doc_number] => 05854211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Compounds with growth hormone releasing properties' [patent_app_type] => 1 [patent_app_number] => 8/464679 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6956 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 402 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854211.pdf [firstpage_image] =>[orig_patent_app_number] => 464679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745972 [patent_doc_number] => 05716929 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Inhibitors of interleukin-1.beta. converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/464964 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59073 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716929.pdf [firstpage_image] =>[orig_patent_app_number] => 464964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687785 [patent_doc_number] => 05696089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Histidine substituted growth hormone releasing factor analogs' [patent_app_type] => 1 [patent_app_number] => 8/461218 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8636 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696089.pdf [firstpage_image] =>[orig_patent_app_number] => 461218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004098 [patent_doc_number] => 06004927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Method for increasing bioavailability of orally administered pharmaceutical compounds' [patent_app_type] => 1 [patent_app_number] => 8/462757 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12899 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004927.pdf [firstpage_image] =>[orig_patent_app_number] => 462757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3982986 [patent_doc_number] => 05958883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Animal models of human amyloidoses' [patent_app_type] => 1 [patent_app_number] => 8/461216 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 100 [patent_no_of_words] => 39015 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958883.pdf [firstpage_image] =>[orig_patent_app_number] => 461216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697951 [patent_doc_number] => 05677276 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Immobilization of peptides to hyaluronate' [patent_app_type] => 1 [patent_app_number] => 8/469582 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 9755 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677276.pdf [firstpage_image] =>[orig_patent_app_number] => 469582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628190 [patent_doc_number] => 05686413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Ractopamine and growth hormone combinations' [patent_app_type] => 1 [patent_app_number] => 8/462099 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3548 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686413.pdf [firstpage_image] =>[orig_patent_app_number] => 462099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923789 [patent_doc_number] => 05914314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals' [patent_app_type] => 1 [patent_app_number] => 8/462614 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20281 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914314.pdf [firstpage_image] =>[orig_patent_app_number] => 462614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889540 [patent_doc_number] => 05750103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Method for transplanting cells into the brain and therapeutic uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/460700 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10693 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750103.pdf [firstpage_image] =>[orig_patent_app_number] => 460700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886665 [patent_doc_number] => 05714460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'IFG-1 to improve neural outcome' [patent_app_type] => 1 [patent_app_number] => 8/460365 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7359 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714460.pdf [firstpage_image] =>[orig_patent_app_number] => 460365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410922 [patent_doc_number] => 06310144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Reinforced rubber article, production thereof and rubber composition suitable therefor' [patent_app_type] => 1 [patent_app_number] => 8/459678 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7676 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310144.pdf [firstpage_image] =>[orig_patent_app_number] => 459678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3844966 [patent_doc_number] => 05708138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Immunoreactive peptides of apo(a)' [patent_app_type] => 1 [patent_app_number] => 8/457449 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 10436 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708138.pdf [firstpage_image] =>[orig_patent_app_number] => 457449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769294 [patent_doc_number] => 05773413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method of combating mammalian neoplasias, and lytic peptides therefor' [patent_app_type] => 1 [patent_app_number] => 8/457171 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12693 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773413.pdf [firstpage_image] =>[orig_patent_app_number] => 457171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895538 [patent_doc_number] => 05750500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Process for inhibiting activity of endotoxin' [patent_app_type] => 1 [patent_app_number] => 8/455563 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 9541 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750500.pdf [firstpage_image] =>[orig_patent_app_number] => 455563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743648 [patent_doc_number] => 05801141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Implant compositions containing a biologically active protein, peptide or polypeptide' [patent_app_type] => 1 [patent_app_number] => 8/456167 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9209 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801141.pdf [firstpage_image] =>[orig_patent_app_number] => 456167 [rel_patent_id] =>[rel_patent_doc_number] =>)